Todd A. Huffman
Fundador en Padlock Therapeutics, Inc. .
Perfil
Todd A.
Huffman is the founder of Padlock Therapeutics, Inc., which was founded in 2014.
He holds the title of Director at Padlock Therapeutics, Inc. Dr. Huffman is currently working as the Director-Clinical Translation Initiative at The University of Virginia School of Medicine.
Dr. Huffman previously worked as an Analyst at RCT BioVentures from 2007 to 2010.
Dr. Huffman obtained a doctorate degree from the University of Virginia in 2005.
Cargos activos de Todd A. Huffman
Empresas | Cargo | Inicio |
---|---|---|
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Fundador | 01/01/2014 |
The University of Virginia School of Medicine | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Todd A. Huffman.
Empresas | Cargo | Fin |
---|---|---|
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Analista de Capital Privado | 30/03/2010 |
Formación de Todd A. Huffman.
University of Virginia | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Finance |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Todd A. Huffman